They can stimulate cell growth through activation of Ras, Rac, Rho, CDC42 and their downstream pathways [88,89,90], which have been found to be hyperactivated in several cancers, contributing to tumor growth, angiogenesis, EMT, migration, and invasion [91]. Here, AKT1 is linked to cancer.